Editorial: Methods and application in cardiovascular and smooth muscle pharmacology: 2021

Front Pharmacol. 2022 Oct 21:13:1049022. doi: 10.3389/fphar.2022.1049022. eCollection 2022.

Ahmed F El-Yazbi^{1

2}, Ali H Eid³, Fouad A Zouein^{4

5

6

7}, Khaled S Abd-Elrahman^{1

8

9}

¹ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
² Faculty of Pharmacy, Alamein International University, Al Alamein, Egypt.
³ Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar.
⁴ Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
⁵ Department of Signaling and Cardiovascular Pathophysiology, UMR-S 1180, Inserm, Université Paris-Saclay, Paris-Saclay, France.
⁶ The Cardiovascular Renal and Metabolic Diseases Research Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
⁷ Department of Pharmacology and Toxicology, School of Medicine, University of Mississippi Medical Center, Jackson, MS, United States.
⁸ Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
⁹ Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates.

No abstract available

Keywords: biomarkers; biomedical research; cardiovasclar disease; disease outcome; natural products.

Publication types